Clinical Trial Update: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of motexafin gadolinium and temozolomide in malignant gliomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Brain Neoplasm
• Glioblastoma
• Glioma
• Oligodendroglioma

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Glioma, Glioblastoma | Phase 1 | Status: COMPLETED